*AdvaCare Ranitidine HCL Injection is GMP certified.
**AdvaCare Ranitidine HCL Injection is manufactured in our facilities located in China/India/USA.
50mg/2ml
10 ampoules/box;100 ampoules/box
Antihistamine, Gastrointestinal
Ranitidine Hydrochloride
Product Information
General Information:
AdvaCare is a GMP manufacturer of Ranitidine HCL injection.
Ranitidine HCL injection is indicated for the treatment of duodenal ulcer, benign gastric ulcer, post-operative ulcer, reflux oesophagitis, and Zollinger-Ellison syndrome. It also used to treat conditions that need a reduction of gastric secretion and acid output.
Ranitidine HCL injection is available in 2mL ampoules that contain 50mg Ranitidine in 2mL aqueous solution. Each 1mL contains 25mg of Ranitidine.
Side Effects:
As with all pharmaceuticals, some unwanted effects can occur from the use of Ranitidine HCL Injection. Always consult a doctor or health care professional for medical advice before use.
Common side effects include, but may not be limited to dizziness, drowsiness, and swelling near the injection site. Seek medical attention if the following develop: an allergic reaction (itching, hives, swelling, & breathing problems), fainting, blurred vision, anxiety, restlessness, abnormal heartbeat, ringing in ears, severe headache, or trouble breathing.
For a comprehensive list of all possible effects, consult your doctor.
If any symptom persists or gets worse, or you notice any other symptom, please call your doctor immediately.
-
For more information about our Ranitidine HCL Injection
email us at: info@advacarepharma.com
Additional Information
Always consult your doctor or pharmacist before administering Ranitidine HCL Injection.
If your condition does not improve or becomes worse, then call your doctor.
As Ranitidine HCL Injection can make you feel dizzy or drowsy, avoid driving or operating machinery until you know how the medication affects you.
Do NOT use Ranitidine Hydrochloride Injection if:
- You are allergic to Ranitidine Hydrochloride Injection or any other containing ingredients;
- You are allergic to ester-group local anesthetics or substitute products in para of parahydroxybenzoates type.
Use of potassium chloride injection during pregnancy or breast feeding has low risk. Though, it should only be administered when clearly needed in pregnant or nursing mothers. Consult your doctor or health care professional before administering Ranitidine HCL Injection.
Refer to your doctor or pharmacist for guidelines on dosage. Do not exceed what they advise. Usual dose for adults and children depend on the patient and condition. It should be administered intravenously with a calibrated infusion device at a slow and controlled rate. It is recommended not to exceed 10mEQ/hour or 200mEQ/day if the patient’s potassium level is greater than 2.5mEQ/liter.
When using Ranitidine HCL Injection, it is especially important to monitor cardiac function, potassium concentration, and acid-base balance. It should not be infused rapidly in order to avoid potassium intoxication. Do not use other potassium-containing salt substitutes when using Ranitidine HCL Injection. Tell your doctor immediately if you notice confusion, tingling sensations, or severe weakness.
Ranitidine HCL Injection can have interactions with ACE inhibitors, aldosterone blockers, diuretics, and digoxin. These drugs can also affect potassium levels, so it is important to monitor potassium levels when using these drugs concurrently. Consult with your doctor about any medications you are taking and health conditions, such as kidney disease before your treatment with potassium chloride injection.
Interested in more Products?
For more gastrointestinals, you can also check the following related products: